Company Filing History:
Years Active: 1980-1981
Title: **Innovative Contributions of Huibert A Van Riessen in Pharmaceutical Technologies**
Introduction
Huibert A Van Riessen, an accomplished inventor based in Lunteren, Netherlands, has made significant strides in the field of pharmaceutical compositions. With a focus on therapeutic materials, his innovations address challenges such as low solubility in water, ultimately benefiting the administration of essential medications.
Latest Patents
Van Riessen holds two notable patents that demonstrate his commitment to advancing therapeutic solutions. His latest patents involve solvent vehicles specifically designed for parenteral administration. The first patent outlines a solvent vehicle comprising a dialkyl ester of adipic acid and, optionally, DMSO, tailored for therapeutic materials with low solubility. This invention is particularly advantageous for pharmaceutical compositions suitable for intramuscular injection. A preferred embodiment of this invention addresses distomatosis (liver fluke disease) with a composition containing 12.5 g of 4,6'-dichloro-4',6-dinitro-2,2'-methylenediphenol and 30 g of DMSO, combined with di-n-butyl adipate to achieve a total volume of 100 cm³.
Career Highlights
Throughout his career at ACF Chemiefarma N.V., Huibert A Van Riessen has been integral in developing innovative pharmaceutical solutions that enhance therapeutic efficacy and patient outcomes. His inventions not only push the boundaries of pharmaceutical technologies but also stand as a testament to his dedication and expertise in the field.
Collaborations
Van Riessen works alongside esteemed colleagues, including Cornelis A Ladage and Douwe J Van Linge. Their collaborations have yielded essential advancements in pharmaceutical innovations, fostering an environment of shared knowledge and expertise that is crucial in an ever-evolving industry.
Conclusion
In summary, Huibert A Van Riessen is a prominent inventor dedicated to improving pharmaceutical compositions. His innovative patents, particularly in the development of solvent vehicles for therapeutic applications, highlight his contributions to the field. Working within ACF Chemiefarma N.V. alongside accomplished colleagues, his work continues to pave the way for effective treatment options and enhance the overall landscape of pharmaceutical sciences.